Skip to main content

Advertisement

Log in

Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable

  • ORIGINAL
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

Platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF-2) are involved in the development of grade 2 gliomas. The aim of the present study was to determine the presence of these growth factors in the cerebrospinal fluid (CSF) and to assess their usefulness as biological markers. CSF was collected from 7 adult patients with newly diagnosed supratentorial low-grade gliomas by lumbar puncture and was analysed together with matched serum samples using radioreceptor and enzyme-linked immunosorbant assays. Neither PDGF nor VEGF were detected in the CSF, and FGF-2 was measurable at extremely low concentrations in only 2 of 7 patients. Serum levels were within normal limits. We conclude that these growth factors are not released into the CSF in any significant amounts and are therefore not suitable as biological markers in grade 2 gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 22 December 2002 / Accepted in revised form: 27 March 2003

Correspondence to: D. Ribom

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribom, D., Larsson, A., Pietras, K. et al. Growth factor analysis of low-grade glioma CSF: PDGF and VEGF are not detectable. Neurol Sci 24, 70–73 (2003). https://doi.org/10.1007/s100720300075

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100720300075

Navigation